PODOCYTURIA IN FABRY DISEASE IS ELEVATED IN UNTREATED VS TREATED ADULT PATIENTS AND DOES NOT CORRELATE WITH PROTEINURIA OR RENAL FUNCTION

被引：0
|
作者：
Trimarchi, Hernan [1 ]
Canzonieri, Romina [2 ]
Schiel, Amalia [2 ]
Politei, Juan [3 ]
Andrews, Jose [1 ]
Forrester, Mariano [1 ]
Alonso, Mirta [2 ]
Lombi, Fernando [1 ]
Pomeranz, Vanesa [1 ]
Karl, Alejandra [1 ]
Rengel, Tatiana [1 ]
Muryan, Alexis [2 ]
Zotta, Elsa [4 ]
机构：
[1] Hosp Britan Buenos Aires, Nephrol, Buenos Aires, DF, Argentina
[2] Hosp Britan Buenos Aires, Biochem, Buenos Aires, DF, Argentina
[3] Fdn Estudio Enfermedades Neurometab, Lab Neuroquim Dr NA Chamoles, Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, Fac Med, Buenos Aires, DF, Argentina
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP178
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The evolution of renal function in the Czech cohort of patients with Fabry disease
    Dostalova, G.
    Kuchynka, P.
    Palecek, T.
    Lubanda, J. C.
    Bultas, J.
    Golan, L.
    Linhart, A.
    CLINICAL THERAPEUTICS, 2008, 30 : S63 - S64
  • [22] Adult patients with Fabry disease: what does the cardiologist need to know?
    Hagege, Albert A.
    Germain, Dominique P.
    HEART, 2015, 101 (12) : 916 - 918
  • [23] Renal function in patients with Fabry disease: Data from FOS - The Fabry Outcome Survey
    Sunder-Plassmann, Gere
    Beck, Michael
    Clarke, Joe
    Linhart, Ales
    Schiffmann, Raphael
    Mehta, Atul
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 32 - 33
  • [24] The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease
    Satirapoj, Bancha
    Promrattanakun, Anan
    Supasyndh, Ouppatham
    Choovichian, Panbuppa
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2015, 2015
  • [25] Renal function in patients with fabry disease on enzyme replacement therapy (ERT)
    West, Michael
    Cybulla, Markus
    Feriozzi, Sandro
    Schwarting, Andreas
    Schiffmann, Raphael
    Mehta, Atul
    Sunder-Plassmann, Gere
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 13 - 13
  • [26] Agalsidase alfa prevents the decline in renal function in patients with Fabry disease
    Schwarting, A
    Dehout, F
    Feriozzi, S
    Beck, M
    Mehta, A
    Widmer, U
    Sunder-Plassmann, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V248 - V248
  • [27] Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease
    Feriozzi, Sandro
    Schwarting, Andreas
    Sunder-Plassmann, Gere
    West, Michael
    Cybulla, Markus
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (05) : 353 - 361
  • [28] Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy
    Suntjens, Eefje B.
    Smid, Bouwien E.
    Biegstraaten, Marieke
    Dreschler, Wouter A.
    Hollak, Carla E. M.
    Linthorst, Gabor E.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2015, 38 (02) : 351 - 358
  • [29] Enzyme replacement therapy and renal function in 201 patients with Fabry disease
    Schwarting, A.
    Dehout, F.
    Feriozzi, S.
    Beck, M.
    Mehta, A.
    Sunder-Plassmann, G.
    CLINICAL NEPHROLOGY, 2006, 66 (02) : 77 - 84
  • [30] Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study
    Feriozzi, Sandro
    Linhart, Ales
    Ramaswami, Uma
    Kalampoki, Vasiliki
    Gurevich, Andrey
    Hughes, Derralynn
    CLINICAL THERAPEUTICS, 2020, 42 (12) : 2321 - 2330
12345